Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Benzylpenicilloyl polylysine
Drug ID BADD_D00251
Description Benzylpenicilloyl polylysine is used as a skin-testing reagent to detect immunoglobulin E antibodies in people with a history of penicillin allergy. The quantitation of in vitro IgE antibodies to the benzylpenicilloyl determinant is a useful tool for evaluating allergic subjects.
Indications and Usage For use as a adjunct in assessing the risk of administering penicillin (benzylpenicillin or penicillin G).
Marketing Status approved
ATC Code Not Available
DrugBank ID DB00895
KEGG ID D03095
MeSH ID C509029
PubChem ID 45266800
TTD Drug ID D0J7TM
NDC Product Code 49471-001
UNII 76479814OY
Synonyms benzylpenicilloyl G polylysine | BPO-oligolysine | benzylpenicilloyl-G-polylysine
Chemical Information
Molecular Formula C28H46N6O8S
CAS Registry Number 31855-75-1
SMILES CC1(C(NC(S1)C(C(=O)NCCCCC(C(=O)O)N)NC(=O)CC2=CC=CC=C2)C(=O)O)C.C(CCN)CC(C(=O)O)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Angioedema23.04.01.001; 10.01.05.009; 22.04.02.008--Not Available
Dyspnoea02.11.05.003; 22.02.01.004--
Erythema23.03.06.001--Not Available
Hypotension24.06.03.002--
Pruritus23.03.12.001--
Urticaria23.04.02.001; 10.01.06.001--
The 1th Page    1    Total 1 Pages